Eventide Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Eventide Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-689,732	Closed	-$79.8M	–	174
2023 Q3	$79.8M	Buy	689,732 +24	+0%	+$2.58K	1.43%	20
2023 Q2	$70.9M	Sell	689,708 -110,743	-14%	-$11.7M	1.2%	30
2023 Q1	$87.4M	Sell	800,451 -195,749	-20%	-$21.6M	1.6%	16
2022 Q4	$113M	Buy	996,200 +25,000	+3%	+$2.08M	2.24%	8
2022 Q3	$60.1M	Buy	971,200 +901,400	+1,291%	+$63M	1.18%	30
2022 Q2	$5.57M	Buy	+69,800	New	+$6.61M	0.12%	115

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return